Sei Investments CO Ovid Therapeutics Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.85 - $2.26 $72,438 - $88,492	-39,156 Reduced 53.65%	33,832 $62,000
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.31 $78,358 - $153,471	-46,366 Reduced 38.85%	72,988 $157,000
Q4 2021 Feb 14, 2022	BUY	$3.13 - $3.73 $120,996 - $144,190	38,657 Added 47.9%	119,354 $383,000
Q2 2021 Aug 06, 2021	BUY	$3.3 - $4.49 $266,300 - $362,329	80,697 New	80,697 $316,000
Q3 2018 Nov 08, 2018	SELL	$5.6 - $11.0 $543 - $1,067	-97 Closed	0 $0

Q2 2018 Aug 03, 2018	BUY	$6.16 - $10.14 $597 - $983	97 New	97 $1,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.